Pablo Legorreta, Royalty Pharma CEO (Photographer: Patrick T. Fallon/Bloomberg via Getty Images)
Pablo capitalized: Royalty Pharma scores $2.2B IPO — the biggest of the year
A pharma IPO has snatched the crown for the largest US listing of the year.
Royalty Pharma raised $2.2 billion — the exact amount outlined in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
